Renata Pasqualini
Overview
Explore the profile of Renata Pasqualini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
7020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cararo-Lopes E, Sawant A, Moore D, Ke H, Shi F, Laddha S, et al.
medRxiv
. 2023 Mar;
PMID: 36945575
Translational Relevance: In this article, we propose a new integrated metabolic, genomic, and cytopathologic methods to diagnose Differentiated Thyroid Cancer when the conventional methods failed. Moreover, we suggest metabolic and...
12.
Lauer R, Barry M, Smith T, Thomas A, Wu J, Du R, et al.
Elife
. 2023 Jan;
12.
PMID: 36645410
Background: We have previously shown that the long non-coding (lnc)RNA (; formerly ) functions as a trans-dominant negative oncogene by targeting the previously unrecognized prostate cancer suppressor gene (a homolog...
13.
Giannou A, Kempski J, Shiri A, Lucke J, Zhang T, Zhao L, et al.
Immunity
. 2023 Jan;
56(1):125-142.e12.
PMID: 36630911
During metastasis, cancer cells invade, intravasate, enter the circulation, extravasate, and colonize target organs. Here, we examined the role of interleukin (IL)-22 in metastasis. Immune cell-derived IL-22 acts on epithelial...
14.
Dogra P, Schiavone C, Wang Z, Ruiz-Ramirez J, Caserta S, Staquicini D, et al.
medRxiv
. 2022 Nov;
PMID: 36415468
While the development of different vaccines has slowed the dissemination of SARS-CoV-2, the occurrence of breakthrough infections continues to fuel the pandemic. As a strategy to secure at least partial...
15.
Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells
Ferrer A, Kenfack Y, Petryna A, Arap W, Pasqualini R, Rameshwar P
Oncoscience
. 2022 Sep;
9:42-48.
PMID: 36110329
Breast cancer (BC) metastasis can occur decades before clinical diagnosis. During this time, the cancer cells (BCCs) can remain dormant for decades. This type of dormancy also occurs during remission...
16.
Shaheen M, Tse J, Sokol E, Masterson M, Bansal P, Rabinowitz I, et al.
Elife
. 2022 Jul;
11.
PMID: 35787784
Background: Lymphatic malformations (LMs) often pose treatment challenges due to a large size or a critical location that could lead to disfigurement, and there are no standardized treatment approaches for...
17.
Markosian C, Staquicini D, Dogra P, Dodero-Rojas E, Lubin J, Tang F, et al.
Mol Biol Evol
. 2022 May;
39(5).
PMID: 35511693
Evaluation of immunogenic epitopes for universal vaccine development in the face of ongoing SARS-CoV-2 evolution remains a challenge. Herein, we investigate the genetic and structural conservation of an immunogenically relevant...
18.
Dogra P, Ramirez J, Butner J, Pelaez M, Chung C, Hooda-Nehra A, et al.
Pharm Res
. 2022 Mar;
39(3):511-528.
PMID: 35294699
Purpose: Downregulation of miRNA-22 in triple-negative breast cancer (TNBC) is associated with upregulation of eukaryotic elongation 2 factor kinase (eEF2K) protein, which regulates tumor growth, chemoresistance, and tumor immunosurveillance. Moreover,...
19.
Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats
Kamal S, Potukutchi S, Gelovani D, Bonomi R, Kallakuri S, Cavanaugh J, et al.
Mol Psychiatry
. 2022 Jan;
27(3):1683-1693.
PMID: 35027678
The fundamental role of epigenetic regulatory mechanisms involved in neuroplasticity and adaptive responses to traumatic brain injury (TBI) is gaining increased recognition. TBI-induced neurodegeneration is associated with several changes in...
20.
Lubin J, Markosian C, Balamurugan D, Pasqualini R, Arap W, Burley S, et al.
bioRxiv
. 2021 Dec;
PMID: 34931193
There is enormous ongoing interest in characterizing the binding properties of the SARS-CoV-2 Omicron Variant of Concern (VOC) (B.1.1.529), which continues to spread towards potential dominance worldwide. To aid these...